AT1 receptor expressed in the cardiovascular system has been shown to activate a variety of intracellular protein kinases that stimulate NADPH oxidase, ROS generation and protein synthesis, causing hypertrophy, hyperplasia and migration of VSMCs, cardiac hypertrophy and renal deterioration (Kawai et al., 2017). Here, FMO5 is linked to cardiac hypertrophy.